BLA Regulatory
BLA Regulatory offers expert FDA regulatory consulting and U.S. Agent representation for drug and medical device companies. They facilitate IND filings, clinical trial strategy, and navigate complex regulatory pathways.
BLA Regulatory is a specialized consulting firm providing comprehensive regulatory services for drug and medical device companies seeking to enter or operate within the U.S. market. With extensive experience in IND filings, clinical trial registration, and strategy development, they act as a crucial U.S. Agent, facilitating interaction with the FDA on behalf of foreign sponsors. Their expertise spans the entire product lifecycle, from initial research and nonclinical development through submission, approval, and post-market maintenance. BLA Regulatory excels in formalizing meetings with regulatory agencies, providing critical regulatory insight, and ensuring operational efficiency. They offer tailored end-to-end approaches, translating complex regulatory requirements into actionable plans to expedite product development and market entry. BLA Regulatory's services are designed to support companies, particularly startups and small biotechs, in navigating the intricacies of FDA compliance. They offer guidance on medical device classification through 513(g) requests, develop robust IND/CTA strategies with NDA/BLA submissions in mind, and provide essential support for clinical trial recruitment and registration. Their team of FDA-experienced experts, industry leaders, and regulatory professionals ensures clients receive competent and reliable support to achieve their development and commercialization goals.
About
**Who they are**
BLA Regulatory provides expert FDA regulatory consulting and U.S. Agent representation for drug and medical device companies. They facilitate IND filings, clinical trial strategy, and navigate complex regulatory pathways.
**Expertise & scope**
* U.S. Agent Representation: Facilitating interaction with the FDA for foreign sponsors, offering regulatory insight and operational efficiency beyond basic communication.
* IND Filing & Maintenance: Assisting sponsors in compiling robust data sets for Investigational New Drug Applications, including drug manufacturing, purity, potency, animal testing results, and human trial plans.
* Health Authority Meetings: Strategizing and preparing for formal meetings with regulatory agencies (FDA) to discuss development programs, resolve issues, and obtain approvals for clinical trials or product licenses.
* Regulatory Strategy Development: Creating tailored end-to-end approaches for product development, from research and nonclinical stages through submission, approval, and maintenance.
* Gap Analysis: Conducting logical and scientific reviews of available information to forecast product success and form the basis for preliminary discussions with regulatory agencies.
* Medical Writing: Developing quality regulatory, clinical, and scientific documents, adhering to guidelines such as ICH-GCP, FDA, and EMA, and managing submissions in eCTD and CTD modules.
**Reputation / proof points**
* Functions as an extension of the client's internal team to ensure compliance.
* Possesses deep industry expertise and regulatory intelligence.
* Experience includes teleconferences, face-to-face meetings, and written correspondences with various FDA offices and divisions.
BLA Regulatory provides expert FDA regulatory consulting and U.S. Agent representation for drug and medical device companies. They facilitate IND filings, clinical trial strategy, and navigate complex regulatory pathways.
**Expertise & scope**
* U.S. Agent Representation: Facilitating interaction with the FDA for foreign sponsors, offering regulatory insight and operational efficiency beyond basic communication.
* IND Filing & Maintenance: Assisting sponsors in compiling robust data sets for Investigational New Drug Applications, including drug manufacturing, purity, potency, animal testing results, and human trial plans.
* Health Authority Meetings: Strategizing and preparing for formal meetings with regulatory agencies (FDA) to discuss development programs, resolve issues, and obtain approvals for clinical trials or product licenses.
* Regulatory Strategy Development: Creating tailored end-to-end approaches for product development, from research and nonclinical stages through submission, approval, and maintenance.
* Gap Analysis: Conducting logical and scientific reviews of available information to forecast product success and form the basis for preliminary discussions with regulatory agencies.
* Medical Writing: Developing quality regulatory, clinical, and scientific documents, adhering to guidelines such as ICH-GCP, FDA, and EMA, and managing submissions in eCTD and CTD modules.
**Reputation / proof points**
* Functions as an extension of the client's internal team to ensure compliance.
* Possesses deep industry expertise and regulatory intelligence.
* Experience includes teleconferences, face-to-face meetings, and written correspondences with various FDA offices and divisions.
Additional information
BLA Regulatory emphasizes a tailored, end-to-end approach, acting as an extension of your internal team to ensure product development and marketing programs comply with regulatory requirements. Their services are designed to efficiently guide products through the drug development cycle, from initial research to post-approval maintenance. They focus on translating complex regulatory requirements into actionable plans, aiming to enhance the success and progress of potential products by providing expert analysis and strategic guidance.
Key Highlights
-
Provides U.S. Agent representation for foreign sponsors to interact with the FDA.
Source
“Foreign sponsors of drug applications who want to conduct business in the United States need an authorized U.S. Agent to interact with the FDA on their behalf.”
-
Assists with Investigational New Drug (IND) filings and maintenance.
Source
“BLA Regulatory works with our clients, the sponsors, to present the best case to the regulators by compiling a robust data set describing how the drug is made and determined to be pure and potent...”
-
Offers strategic planning for health authority meetings with the FDA.
Source
“Formalized meetings with regulatory agencies are needed for both drugs in development and to respond to post-marketing questions to maintain and develop existing drugs.”
-
Develops comprehensive regulatory strategies from product research to post-approval.
Source
“BLA Regulatory provides comprehensive strategy and operations services to guide you through every step of the regulatory process.”
-
Conducts regulatory gap analyses to forecast product success.
Source
“A gap analysis is a powerful tool that can be used to forecast a product’s success.”
-
Provides expert medical writing services for regulatory documents.
Source
“Our team of qualified and experienced Medical Writers is well equipped to write a wide range of Regulatory, Clinical and Scientific documents.”
Certifications & Trust Signals
-
Operates from Gaithersburg, MD, USA.
Source
“610 Professional Dr. Suite 225 Gaithersburg, MD 20879”
-
Experience includes interactions with various FDA offices and divisions.
Source
“Our past interactions with the FDA include teleconferences, face-to-face meetings, and written correspondences with a wide array of FDA offices and divisions.”
Buyer Snapshot
Best for
- Foreign sponsors needing FDA U.S. Agent representation
- Companies navigating IND filings and clinical trial strategy
- Firms requiring expert FDA regulatory consulting
How engagement typically works
- Collaborative, acting as an extension of the internal team
- Tailored, end-to-end approach based on client needs
- Focus on regulatory insight and operational efficiency
Typical deliverables
- U.S. Agent representation services
- IND application support and maintenance
- Health authority meeting preparation and strategy
- Regulatory strategy development plans
- Gap analysis reports
- Medical and regulatory documentation
Good to know
- Best when requiring specialized FDA regulatory expertise for drug and medical device companies.
HQ:
Gaithersburg, US
Languages:
English
Timezones:
America/New_York
Claim status:
Listed
Services & Capabilities
Best FDA US Agent Services | Compare & Get Quotes
Jurisdictions:
US
Countries:
US
Industries:
Medical devices, Drugs
Portfolio:
6-25, 26-100, 100+
Onboarding time:
2–7 days
Pricing model:
Retainer
Starting from:
USD 1,700
Included services:
FDA communications handling, Establishment registration support, Product listing assistance, Regulatory submission support, Compliance consulting
Product Type:
drugs, devices
Service Types:
US Agent Services, FDA Registration/Listing Support, FDA Submissions (510(k), PMA, IDE, etc.), Regulatory Consulting
Additional us_agent_fda Details
Product Types
Drugs, Medical Devices
Registration Support
Implied through U.S. Agent services and IND filings
Recall Support
No explicit mention
Inspection Support
No explicit mention
Emergency Contact24x7
No explicit mention
US Entity State
MD
Onboarding Steps
No explicit mention
⚡ Instant booking available
Appoint a Vetted FDA U.S. Agent in 2 Minutes
Compare BLA Regulatory and other vetted providers — instant pricing, no RFQ needed.
